Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/25802
Full metadata record
DC FieldValueLanguage
dc.contributor.authorElliott, Sarah-
dc.contributor.authorBerlangieri, Alexandra-
dc.contributor.authorWasiak, Jason-
dc.contributor.authorChao, Michael-
dc.contributor.authorForoudi, Farshad-
dc.date2021-02-01-
dc.date.accessioned2021-02-07T23:58:07Z-
dc.date.available2021-02-07T23:58:07Z-
dc.date.issued2021-02-01-
dc.identifier.citationSystematic Reviews 2021; 10(1): 44en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/25802-
dc.description.abstractIn recent years, we have seen the incorporation of magnetic resonance imaging (MRI) simulators into radiotherapy centres and the emergence of the new technology of MR linacs. However, the significant health care resources associated with this advanced technology impact immediate widespread use and availability. There are currently limited studies to demonstrate the clinical effectiveness and inform decision-making on the use of MRI in radiotherapy. The objective of this scoping review is to identify and map the existing evidence surrounding the clinical implementation of MRI-guided radiotherapy in patients with breast cancer. It also aims to identify challenges and knowledge gaps in the literature. We will perform a comprehensive search in MEDLINE and EMBASE databases from January 2010 onwards. Grey literature sources will include the WHO International Clinical Trials Registry Platform. We will include systematic reviews, randomised and non-randomised controlled studies published in English. Literature should examine the use of magnetic resonance imaging-guided radiotherapy in adults with breast cancer, regardless of cancer stage or severity. Two reviewers will independently screen all titles, abstracts and full-text reports. Data will be extracted and summarised using qualitative (e.g. content and thematic analysis) methods and presented in tables. The results from this review will consolidate the evidence surrounding MRI-guided radiotherapy for breast cancer, contributing to the development and optimisation of patient selection, simulation, planning, treatment delivery, quality assurance and research, to help improve patient outcomes, cancer care and treatment for women with breast cancer. The protocol is available on Open Science Framework at DOI https://doi.org/10.17605/OSF.IO/8TEV6.en
dc.language.isoeng
dc.subjectBreast canceren
dc.subjectMR linacen
dc.subjectMR simulationen
dc.subjectMRI-guided radiotherapyen
dc.subjectScoping reviewen
dc.titleUse of magnetic resonance imaging-guided radiotherapy for breast cancer: a scoping review protocol.en
dc.typeJournal Articleen
dc.identifier.journaltitleSystematic Reviewsen
dc.identifier.affiliationRadiation Oncologyen
dc.identifier.affiliationOlivia Newton-John Cancer Wellness and Research Centreen
dc.identifier.doi10.1186/s13643-021-01594-9en
dc.type.contentTexten
dc.identifier.orcid0000-0002-7500-8483en
dc.identifier.pubmedid33526097
Appears in Collections:Journal articles
Show simple item record

Page view(s)

24
checked on Sep 3, 2021

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.